Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Kasha delivers pharmaceutical products and household goods to low-income consumers, resellers, pharmacies, and health facilities.
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Click Therapeutics develops software as a medical treatment prescription platform designed to deliver digital treatments for patients.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
Sanofi has invested in 127 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, EuroAPI received $825.5M in a Post Ipo Debt round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $103.0M across its portfolio of 127 companies.
Recent Sanofi portfolio additions include Lifordi Immunotherapeutics, Imbria Pharmaceuticals, Electra Therapeutics, Expedition Therapeutics, QuantHealth. These companies were founded in 2020 or later.